SCM
CNTX icon

Sterling Capital Management’s Context Therapeutics CNTX Stock Holding History

Sterling Capital Management’s Portfolio CNTX Stock Details CNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$181 Buy
+327
New +$663 ﹤0.01% 3263

Other funds holding CNTX

New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
SFG
Strive Financial Group Carmel, Indiana $231M AUM
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Sterling Capital Management's CNTX Position: Q2 2026 in Review

Sterling Capital Management opened a new position in Context Therapeutics (CNTX) in Q2 2026: 327 shares worth $181. The stake represents ﹤0.01% of the portfolio and ranks #3263 among its holdings.

8 funds tracked by Wall St. Rank hold CNTX as of Q2 2026.

  • Sterling Capital Management held 327 shares of Context Therapeutics worth $181 as of Q2 2026.
  • Context Therapeutics was a new Sterling Capital Management position in Q2 2026.
  • Context Therapeutics made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #3263 holding.
  • 8 funds tracked by Wall St. Rank held Context Therapeutics as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.